A study of multidrug resistant organisms in the adult intensive care unit at Addenbrooke's Hospital

Not Applicable

Completed

• Conditions: Surveillance for multidrug-resistant organisms; Infections and Infestations

• Registration Number: ISRCTN13493757
• Lead Sponsor: Cambridge University Hospitals NHS Foundation Trust

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Completion: 2017-06-30
• Study Start: 2020-02-20
• Last Update Posted: 30 March 2020

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 400

Inclusion Criteria

1. Aged 18 years old or older
2. Male or female
3. Admitted to the John Farman Intensive Care Unit during the study period

Exclusion Criteria

Does not fulfil study inclusion criteria

Study & Design

• Study Type: Observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<br> Measured using patient records during the study period:<br> 1. Number of patients colonised with multidrug-resistant organisms<br> 2. Number of patients with clinical evidence of infection with multidrug-resistant organisms<br> 3. Number of transmission events of multidrug-resistant organisms<br>

Secondary Outcome Measures

Name	Time	Method
<br> Measured using patient records during the study period:<br> 1. Risk factors for colonisation / infection with multidrug-resistant organisms<br> 2. Outcome of patients colonised / infected with multidrug-resistant organisms<br> 3. Cost-consequences of whole-genome sequencing versus standard epidemiological investigation / typing for surveillance and investigation of suspected outbreaks and the management of confirmed outbreaks<br>